113 related articles for article (PubMed ID: 37746995)
21. Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population.
Suzuki O; Eguchi H; Chika N; Sakimoto T; Ishibashi K; Kumamoto K; Tamaru JI; Tachikawa T; Akagi K; Arai T; Okazaki Y; Ishida H
Surg Today; 2017 Sep; 47(9):1135-1146. PubMed ID: 28258479
[TBL] [Abstract][Full Text] [Related]
22. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
[TBL] [Abstract][Full Text] [Related]
23. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
[TBL] [Abstract][Full Text] [Related]
24. Mismatch Repair Deficient (dMMR) Colorectal Carcinoma in a Pakistani Cohort: Association With Clinical and Pathological Parameters.
Hashmi AA; Bukhari U; Rizwan R; Faisal F; Kumar R; Malik UA; Zia S; Khan AR; Sham S; Irfan M
Cureus; 2023 Aug; 15(8):e42781. PubMed ID: 37664303
[TBL] [Abstract][Full Text] [Related]
25. Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis.
Haraldsdottir S; Roth R; Pearlman R; Hampel H; Arnold CA; Frankel WL
Fam Cancer; 2016 Apr; 15(2):253-60. PubMed ID: 26666765
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
28. An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes.
Jaffrelot M; Farés N; Brunac AC; Laurenty AP; Danjoux M; Grand D; Icher S; Meilleroux J; Mery E; Buscail E; Maulat C; Toulas C; Vande Perre P; Chipoulet E; Bonnet D; Staub A; Guimbaud R; Selves J
Mod Pathol; 2022 Mar; 35(3):427-437. PubMed ID: 34545179
[TBL] [Abstract][Full Text] [Related]
29. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.
Clay MR; Allison KH; Folkins AK; Longacre TA
Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635
[TBL] [Abstract][Full Text] [Related]
30. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and molecular characterization of deficient mismatch repair colorectal cancer.
Yamada A; Yamamoto Y; Minamiguchi S; Kamada M; Sunami T; Ohashi S; Seno H; Kawada K; Muto M
Hum Pathol; 2022 Dec; 130():1-9. PubMed ID: 36150551
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic and Molecular Characteristics of Synchronous Colorectal Carcinoma With Mismatch Repair Deficiency.
Nakano K; Yamamoto H; Fujiwara M; Koga Y; Tsuruta S; Ihara E; Oki E; Nakamura M; Ogawa Y; Oda Y
Am J Surg Pathol; 2018 Feb; 42(2):172-182. PubMed ID: 28877066
[TBL] [Abstract][Full Text] [Related]
33. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
Walker R; Mahmood K; Joo JE; Clendenning M; Georgeson P; Como J; Joseland S; Preston SG; Antill Y; Austin R; Boussioutas A; Bowman M; Burke J; Campbell A; Daneshvar S; Edwards E; Gleeson M; Goodwin A; Harris MT; Henderson A; Higgins M; Hopper JL; Hutchinson RA; Ip E; Isbister J; Kasem K; Marfan H; Milnes D; Ng A; Nichols C; O'Connell S; Pachter N; Pope BJ; Poplawski N; Ragunathan A; Smyth C; Spigelman A; Storey K; Susman R; Taylor JA; Warwick L; Wilding M; Williams R; Win AK; Walsh MD; Macrae FA; Jenkins MA; Rosty C; Winship IM; Buchanan DD;
J Transl Med; 2023 Apr; 21(1):282. PubMed ID: 37101184
[TBL] [Abstract][Full Text] [Related]
34. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
[TBL] [Abstract][Full Text] [Related]
35. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
Jessup CJ; Redston M; Tilton E; Reimann JD
Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
[TBL] [Abstract][Full Text] [Related]
36. Universal tumor screening in a population with MSH6- and PMS2-associated Lynch syndrome.
Einarsson H; Runarsdottir JR; Tryggvason T; Snaebjornsson P; Smaradottir A; Stefansdottir V; Thoroddsen A; Arngrimsson R; Jonasson JG; Haraldsdottir S
Genet Med; 2022 May; 24(5):999-1007. PubMed ID: 35172941
[TBL] [Abstract][Full Text] [Related]
37. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
Zakout YM; Lanza G
J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
[TBL] [Abstract][Full Text] [Related]
38. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
[TBL] [Abstract][Full Text] [Related]
39. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.
Jin HY; Liu X; Li VK; Ding Y; Yang B; Geng J; Lai R; Ding S; Ni M; Zhao R
BMC Cancer; 2008 Feb; 8():44. PubMed ID: 18257912
[TBL] [Abstract][Full Text] [Related]
40. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]